治験業務データの統合と活用:ポータル、データ・ウェアハウス、治験実施施設/治験実施評価基準
DATA INTEGRATION ACROSS MULTIPLE VENDOR
AND INTERNAL PLATFORMS
-ベンダーおよび社内の複合プラットフォームにおけるデータ統合-
Data Warehousing 2.0: Creating an Integrated Data Environment For Clinical Trials
Munther Baara, Senior Director, Development Business Technology, Pfizer
Data Integration Challenges and Considerations
Ramzi Najm, Vice President, R&D Information and Technology Management, Allergan
WEB PORTALS IN CLINICAL TRIALS:
THE FUTURE IS NOW
-治験におけるウェブポータル:未来は現在-
Web Portals in Clinical Trials
Jeanette Teague, Associate Director, eDC Operations, Bristol-Myers Squibb Co.
Portals in Clinical Operation: User Experience at the Center of Attention
Anna Kravets, Director, User Experience Strategy, Merck
IMPROVING TECHNOLOGY UTILIZATION:
CASE STUDIES
-技術活用の改善:ケーススタディ-
The Electronic Clinical Trial Master File at BI
Kristin K. O'Connor, Executive Director, Project Management and Medical Administration, Boehringer Ingelheim Pharmaceuticals
Data Driven Monitoring Visit
Adrian Hsing, Senior Director Clinical Operations, Elan Pharmaceuticals
Data Warehouses: More Than a Version Controlled Data Repository
Greg Moody, Director, Clinical Systems, Millennium: The Takeda Oncology Company
Sponsored by
Clinical Operational Excellence
Eric Lake, Partner, Pharmica Consulting
IMPROVING SITE AND STUDY EXECUTION METRICS
-治験実施施設および治験実施評価指標の改善-
Shared session with Patient Recruitment and Retention and Clinical Trial Forecasting, Budgeting, and Project Management
Where Are We Now? Looking at Industry Metrics to Overcome Bottlenecks of Study Start-Up
Christine Pierre, Founder and CEO, RxTrials, Inc., The Clinical Trials Transformation Initiative (CTTI)
Internal Benchmark Performance Standards and Metrics: Improving Performance and Accountability by Providing Context for Planning and Gap Analysis
Speaker to be Announced
Sponsored by
Data, Data Everywhere, and Not a One to Link
Bonnie Brescia, Founding Principal, BBK Worldwide
Capturing and Analyzing Clin Ops Data to Increase Performance at Site and Organizational Level
Joseph Kim, M.B.A., Clinical Operations Director, Shire
Improving Site and Study Execution Metrics: Measuring Performance in Terms of Monitoring, Site Identification, and Clinical Supply Chain and then Optimizing Trials Accordingly
Speaker to be Announced
BREAKOUT DISCUSSION GROUPS Interactive Breakout Discussion Groups Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the more poignant questions facing the industry. Delegates will join a table of interest to them and become an active part of the discussion at hand. It is an informal, yet informative, format that allows attendees to learn from each other and make some new contacts. To get the most out of this interactive format please come prepared to: share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing. Topics may include:
|
お勧めの月曜午後のショートコース |






